Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China
Haisu Yi(First Affiliated Hospital of Guangzhou Medical University), Ying Feng(First Affiliated Hospital of Guangzhou Medical University), Xinxin Sun(Foshan University), Xuehua Zheng(Chinese Academy of Sciences), Hengchun Li(Chinese Academy of Sciences), Qinghua Ma(Nanjing Agricultural University), Yingkun Zhang(Guangzhou Institutes of Biomedicine and Health), Ling Chen(Guangzhou Institutes of Biomedicine and Health), Zhilong Chen(Xiamen University), Xuegao Yu(Sun Yat-sen University), Wenming Liu(Renji Hospital), Qian Wang(First Affiliated Hospital of Guangzhou Medical University), Mengzhang He(State Administration of Foreign Experts Affairs), Jiankai Deng(Sun Yat-sen University), Yudi Zhang(Zhejiang Cancer Hospital), Tianxin Ji(Second Affiliated Hospital of Guangzhou Medical University)
Cited by 9
Related Papers
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|536
Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 <i>gag</i> Gene
|Journal of Virology|2003|398
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|248
Evaluation of a Compassion Fatigue Resiliency Program for Oncology Nurses
|Oncology nursing forum|2013|187